跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2611.20259 · v1

Scaling large language model-assisted line-of-therapy adjudication with human-in-the-loop evidence-calibrated selection

首次提交 2026-11-16 05:32
版本更新 2026-11-16 05:32
雷达观测 2026-11-17 17:12
arXiv ↗PDF ↗

摘要

Large language models (LLMs) have enabled the ability to scale clinical adjudication tasks traditionally dependent on exhaustive manual review. Line-of-therapy (LoT) adjudication, a major bottleneck in oncology cohort construction, is a prime example. Line boundaries must be inferred from longitudinal treatment histories according to nuanced, study-specific definitions, at every regimen transition for every patient. LLMs can apply this adjudication at scale, but their reliability varies across patients. Treatment histories differ in complexity, and ambiguous or atypical patterns depend on expert clinical judgment. Reliable automation thus requires verified support for model assignments and the ability to identify cases that warrant manual review. Here, we present evidence-calibrated selection (ECS), a human-in-the-loop framework for scaling LLM-assisted LoT adjudication. ECS derives confidence from observed clinician adjudications, prioritizes patients with the least-supported assignments for follow-up review, and returns completed adjudications to the model as precedent. As the evidence base grows, ECS continuously calibrates confidence to estimate residual error, thus enabling more efficient use of clinician time. In simulations on 136 clinician adjudicated patients with multiple myeloma, ECS achieved a residual error of 5% after review of 44.6% of patients, compared to 62.2% when review was directed by LLM self-reported confidence and 81.9% under random sampling. These results support a scalable approach to study-specific LoT adjudication, using clinician evidence to inform automated predictions, minimize error, and reduce review burden.

作者备注:12 pages, 4 figures

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

目前只收录了一个版本。收录下一版后,可以对照标题、作者、分类和摘要。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v1 · 2026-11-16 05:32 · 最新观测版本

Scaling large language model-assisted line-of-therapy adjudication with human-in-the-loop evidence-calibrated selection

Large language models (LLMs) have enabled the ability to scale clinical adjudication tasks traditionally dependent on exhaustive manual review. Line-of-therapy (LoT) adjudication, a major bottleneck in oncology cohort construction, is a prime example. Line boundaries must be inferred from longitudinal treatment histories according to nuanced, study-specific definitions, at every regimen transition for every patient. LLMs can apply this adjudication at scale, but their reliability varies across patients. Treatment histories differ in complexity, and ambiguous or atypical patterns depend on expert clinical judgment. Reliable automation thus requires verified support for model assignments and the ability to identify cases that warrant manual review. Here, we present evidence-calibrated selection (ECS), a human-in-the-loop framework for scaling LLM-assisted LoT adjudication. ECS derives confidence from observed clinician adjudications, prioritizes patients with the least-supported assignments for follow-up review, and returns completed adjudications to the model as precedent. As the evidence base grows, ECS continuously calibrates confidence to estimate residual error, thus enabling more efficient use of clinician time. In simulations on 136 clinician adjudicated patients with multiple myeloma, ECS achieved a residual error of 5% after review of 44.6% of patients, compared to 62.2% when review was directed by LLM self-reported confidence and 81.9% under random sampling. These results support a scalable approach to study-specific LoT adjudication, using clinician evidence to inform automated predictions, minimize error, and reduce review burden.

查看此版本解读 →查看此版本原文 ↗